# A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation

> **NCT00817687** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 66 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil [CellCept]
- **DRUG:** mycophenolate mofetil [CellCept]

## Key facts

- **NCT ID:** NCT00817687
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00817687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00817687, "A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00817687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*